| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 2,262,000 | 2,212,000 | 2,279,000 | 2,195,000 | | Cost of Revenue | (739,000) | 939,000 | 975,000 | (173,000) | | | Gross Profit | 3,001,000 | 1,273,000 | 1,304,000 | 2,368,000 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 2,568,000 | 858,000 | 872,000 | 2,003,000 | | Non Recurring | 526,000 | 10,000 | 6,000 | (456,000) | | Others | (226,000) | 264,000 | 253,000 | 728,000 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 133,000 | 141,000 | 173,000 | 93,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (14,000) | (11,000) | 136,000 |
-
| | Earnings Before Interest And Taxes | 119,000 | 130,000 | 309,000 | 90,000 | | Interest Expense | 112,000 | 120,000 | 110,000 | 106,000 | | Income Before Tax | 7,000 | 10,000 | 199,000 | (16,000) | | Income Tax Expense | 3,000 | 4,000 | 5,000 | (6,000) | | Minority Interest |
-
|
-
|
-
| (3,000) | | | | Net Income From Continuing Ops | 4,000 | 6,000 | 194,000 | (10,000) | | | Non-recurring Events | | Discontinued Operations | (5,000) | (20,000) | (11,000) | (23,000) | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (1,000) | (14,000) | 183,000 | (33,000) | | Preferred Stock And Other Adjustments | 6,000 | (1,000) | (5,000) |
-
| | | Net Income Applicable To Common Shares | ($3,000) | ($15,000) | $178,000 | ($33,000) |
|
1.52% Nasdaq 
Income Statement
